Roundtable Event: Unlocking the potential of artificial intelligence in healthcare

15 November 2021 | 14-15:30 CET

On 21 April 2021, the Commission presented its proposal for a Regulation on the European Approach for AI, which will aim to establish a horizontal framework to foster the development and uptake of AI in a manner which is compatible with EU law and values. Moreover, the Commission opened in June a public consultation regarding its future proposal on the EHDS, planned for Q1 2022, which also addresses the use of AI in healthcare.

Although there are many benefits associated with the use of AI, there are also many challenges and concerns that need to be addressed. The deployment of AI in health raises questions on issues such as the impact on the health workforce, new inequalities, the inclusiveness of AI applications, privacy, trust, data access as well as broader questions on ethical considerations and social implications of its use. Without citizen trust, acceptance and understanding in AI, its full potential will likely not be realised.

Against this background, the Coalition for Health, Ethics and Society (CHES) from the European Policy Centre (EPC) and Healthy Europe have partnered up with the aim to promote a multi-stakeholder dialogue on AI in healthcare by various stakeholders including policy-makers, academia, patient representatives and industry. Unlocking the Potential of Artificial Intelligence in Health & Care will focus on the role of AI in health across the European Union and discuss the role of members states and the EU institutions in addressing the challenges and the societal concerns associated with the use of AI in health.

Introductory remarks

• MEP (TBC)
• Milan Petkovic, Head of Research AI Data Science & Digital Twin, Philips, Healthy Europe Representative

Confirmed speakers

• Rachel Dunscombe (Ex CIO at Salford Royal, Visiting Professor at Imperial, CEO NHS Academy and AI guru)
• Salia Rinne, Head of Sector, eHealth and Ageing Policy, DG CNECT, European Commission
• Claudia Herben, VP Strategic Solutions Medical Devices EMEA, Johnson & Johnson (CHES Corporate Representative)